Clinical Trial Update: Study of a Gene Therapy Treatment for Hemophilia A [Phase 3]

View source ↗

Summary

A Phase 3 gene therapy trial for Hemophilia A sponsored by Spark Therapeutics has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Spark Therapeutics, Inc. | Conditions: Hemophilia A | Phase 3 | Status: WITHDRAWN